Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more) Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Nanalysis Scientific Corp. V.NSCI

Alternate Symbol(s):  NSCIF

Healthcare Medical Devices
Nanalysis develops and manufactures compact MRI and NMR devices for clinical, laboratory, and industrial markets. These portable devices require no liquid helium or any other cryogens. The company’s devices are used in diagnostics and chemical analysis across a range of industries (medical, pharma, biotech, mining, oil and gas, and more) as well as numerous government and university research... see more

TSXV:NSCI - Post Discussion

Nanalysis Scientific Corp. > Nanalysis 2021 Q4 Conference Call Notes and My Commentary
View:
Post by rowdyrhino on Apr 28, 2022 9:46pm

Nanalysis 2021 Q4 Conference Call Notes and My Commentary

Nanalysis 2021 Q4 Conference Call Notes and My Commentary


https://medium.com/me/stats/post/702ac15cdd14
Comment by GoldenArm on Apr 29, 2022 10:11am
Just read you comentary and notice the market reaction this morning. Not much traction on the news but solid performance fram a company expecting 100% growth in 2022. I would estimate that if they can be frugal with spending, hard to do when trying to create a global footprint, We could see breakeven if not profit soon. So the uplisting would have to wait until the end of the year. My opinion is ...more  
Comment by Fredo51545 on May 01, 2022 4:48pm
Well done review. If only $32 mil in 2023 rev including $9 mill from K-Prime, sales only grow 44% organically or $7 million. That is an awfully small increment given the size of the market they are targeting. Frankly, I am puzzled by this. I wonder if Magritek is growing faster? I am using revenue of $35.5 million, with a $7.6 million !Q. Agressive but doable within the confines of their ...more  
Comment by GoldenArm on May 03, 2022 10:57am
Not sure if I understand and don't have time to go back to financials but they said they expect 100% in 2022 not 2023.
Nanalysis Scientific Corp.